Prot #STF 115750: A Phase 1, Open-Label, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Calcipotriene Foam, 0.005%, Applied Under Maximal-Use Conditions in Adolescent Subjects (Ages 12 to 16 Years) with P

Project: Research project

Project Details

Effective start/end date3/13/133/13/20


  • PPD Development (Prot #STF 115750 // Prot #STF 115750)
  • GlaxoSmithKline LLC (Prot #STF 115750 // Prot #STF 115750)